Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576
Published May 21, 2014 · Recall initiated: April 29, 2014
Summary
FDA records drug Class II recall D-1317-2014, published May 21, 2014 and initiated April 29, 2014. Recalling firm: Flawless Beauty LLC; Status: Completed; Reported quantity: unknown; Lot: Lot #: UB302, Exp 05/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Flawless Beauty LLC
- Distributor
- Nationwide
- UPC
- 4973430081576
- Lot
- Lot #: UB302, Exp 05/12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATP Drug Laboratories Vitamin C ampulesFebruary 14, 2018
- FDARelumins Vitamin C Solvent ampulesFebruary 14, 2018
- FDALing Zhi capsulesFebruary 14, 2018
- FDATationil Glutathione, 600 mg/ 4 mL, polvere e solvente per soluzione iniettabile, Teofarma, s.r.l.February 14, 2018
- FDALaroscorbine Platinium (vitamin C/collagen) injectable I.V. solution, 1 gm/0.35 gm, 5 mL ampoules, packaged inMay 21, 2014
- FDASaluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, ExclusivelyMay 21, 2014
Questions about this recall
Was Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576 recalled?
Yes. FDA published recall D-1317-2014 on May 21, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. UPC: 4973430081576.